ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update Life Science Investing
HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results Life Science Investing
Tempest Reports First Quarter 2026 Financial Results and Provides Business Update Life Science Investing
RenovoRx Reports Record First Quarter 2026: Increasing Revenue by 136% Quarter-over-Quarter Life Science Investing
Nurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg in Chronic Spontaneous Urticaria at the 2026 Society for Investigative Dermatology Annual Meeting Life Science Investing
Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference Life Science Investing
Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates Life Science Investing
Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2026 Results Life Science Investing
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology Life Science Investing
Republic Technologies Enters Strategic Software Licensing Partnership with Sign Foundation Medical Device Investing
Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans Life Science Investing
